PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has begun …
![Fluent BioSciences NIH SBIR Phase II Grant](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-pixabay-256262.jpg?resize=365%2C274&ssl=1)
![Fluent BioSciences NIH SBIR Phase II Grant](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-pixabay-256262.jpg?resize=365%2C274&ssl=1)
Fluent BioSciences Awarded NIH SBIR Grant to Revolutionize Single Cell Analysis
Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell …